Company: MDCXW
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001062993-25-008292
Chunk: 132

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-01
Form: DRS
Chunk 132
---
/6/2015 |         |           | 11/6/2035 | Pending | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |
| Korea         | Microneedle arrays for cancer therapy applications | 10-2022-7039076 | 11/6/2014 | 11/6/2015 |         |           | 11/6/2035 | Pending | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |
| Japan         | Microneedle arrays for cancer therapy applications |      2024189676 | 11/6/2014 | 11/6/2015 |         |           | 11/6/2035 | Pending | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |
| Singapore     | Microneedle arrays for cancer therapy applications |     1002004900T | 11/6/2014 | 11/6/2015 |         |           | 11/6/2035 | Pending | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |

<div align='center'>- 88 -</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

<div align='center'>MANAGEMENT</div>

Directors and Executive Officers

The following table sets forth certain information relating to our directors and executive officers as of the date of this prospectus. Directors of Medicus hold office for a one year term and, unless re-elected, will retire from office at the end of the next annual meeting of the shareholders of Medicus. Unless otherwise stated, the business address of our executive officers and directors is our office address at 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

| Name                             |     | Age |     | Position with                                  
 Medicus                                        |
| Dr. Larry Kaiser(1) (5)          |     |  72 |     | Director                                       |
| Robert J. Ciaruffoli(1) (2) (3)  |     |  73 |     | Director                                       |
| Frank Lavelle(1) (2) (4)         |     |  75 |     | Director                                       |
| William L. Ashton(2)